Bradford Crutchfield, Chief Commercial Officer at 10x Genomics, Inc. (TXG), sold 281 shares at $148.38 ($42K) on 2021-11-22, disclosed to the SEC on 2021-11-24.
Open-market sale of $42k TXG by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TXG | SELL | 2022-02-24 | $23K | — | Filing → |
| TXG | SELL | 2022-02-17 | $1.6M | — | Filing → |
| TXG | SELL | 2022-01-14 | $3.5M | — | Filing → |